Phase-1 Executions
Execution Boundary
Phase-1 execution operates strictly within a non-clinical, non-commercial simulation environment.
Phase-1 execution does not:
Control or actuate robotic hardware
Participate in clinical workflows
Integrate live biological, molecular, or patient
License or transfer intellectual property
Engage in commercialization, venture formation, or market activity
Any downstream translation, institutional adoption, or commercialization occurs only outside the Studio boundary under separate, explicitly defined governance.
Representative Phase-1 System Architecture
Acoustic-Guided VR Training and Simulation System Architecture
The following system is presented as a representative example of a Phase-1 execution conducted with the Studio.
This system architecture evaluates whether spatialized audio, combined with immersive simulation, can encode real-time deviation from a target in a manner suitable for precision needle navigation under controlled conditions.
The execution does not assume robotic actuation, clinical workflow integration, or procedural automation. It is treated explicitly as an architectural hypothesis: whether auditory feedback can function as a complementary guidance modality alongside visual feedback for spatial precision within a simulated environment.
What Execution Looks Like
Within the Studio, Phase-1 execution consists of hands-on implementation and evaluation under governed simulation, including:
Implementing spatial audio feedback mapped to real-time needle deviation
Constructing VR simulation environments for controlled task execution
Iterating on feedback encoding strategies (e.g., audio-dominant, vision-assisted)
Measuring variance, convergence, and repeatability across repeated trials
Logging failure modes, discarded approaches, and corrective revisions
Execution is intentionally iterative and evidence driven. Failure is expected, documented, and informative.
Relationship to Intellectual Property
This Phase-1 execution is disclosed in alignment with a filed U.S. provisional patent covering precision robotic surgical intervention system architectures.
Within the Studio, the architecture is treated as an executable architectural hypothesis, subject to validation, correction, or abandonment based on evidence generated through disciplined execution. Phase-1 execution does not imply readiness for deployment, publication, or commercialization.
Inquiry
For research or institutional inquiry consistent with Phase-1 execution scope:
Execution of Architected Systems Under Governed Simulation
Definition: Phase-1 Execution
Phase-1 execution refers to the implementation and evaluation of architected systems under governed simulation to test core architectural assumptions prior to any downstream translation.
Execution at this stage is bounded, non-clinical, and non-commercial. Systems may be refined, corrected, or discontinued based on solely on results generated through disciplined implementation and evaluation.
© 2026 Grasso & Co., LLC. All rights reserved.
DLEV Studio is an internal, non-commercial execution and evaluation initiative of Grasso & Co., LLC.
This site is informational only and does not constitute an offer, solicitation, or agreement.